- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/48 - Aldehydo radicals
Patent holdings for IPC class C07D 213/48
Total number of patents in this class: 33
10-year publication summary
|
2
|
5
|
2
|
2
|
0
|
0
|
0
|
3
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2207 |
6 |
| HotSpot Therapeutics, Inc. | 42 |
3 |
| ExxonMobil Chemical Patents Inc. | 3811 |
2 |
| Arizona Board of Regents on behalf of Arizona State University | 2875 |
2 |
| BASF SE | 21165 |
1 |
| Evonik Degussa GmbH | 1404 |
1 |
| California Institute of Technology | 4023 |
1 |
| Daiichi Sankyo Company, Limited | 1890 |
1 |
| DSM Fine Chemicals Austria NFG GmbH & Co KG | 17 |
1 |
| EpiTherapeutics ApS | 5 |
1 |
| Fibrostatin, Sociedad Limitada | 10 |
1 |
| Fudan University | 748 |
1 |
| Global Blood Therapeutics, Inc. | 176 |
1 |
| M. Technique Co., Ltd. | 252 |
1 |
| Osaka University | 3289 |
1 |
| Piramal Enterprises Limited | 151 |
1 |
| Riken | 1710 |
1 |
| The United States of America, as represented by the Secretary, Department of Health & Human Services | 216 |
1 |
| University of Copenhagen | 428 |
1 |
| Neurosearch A/S | 148 |
1 |
| Other owners | 4 |